ALGN Stock Analysis
NMS · Healthcare · Medical Instruments & Supplies
$144.94
-1.84 (-1.25%)
ALGN Interactive Price Chart & Trading Signals
ALGN Stock Snapshot — Valuation, Risk & Technical Signals
ALGN Key Fundamentals, Analyst Targets & Company Profile
Key Financial Ratios
Market Cap
$10.30B
P/E Ratio
25.21
Forward P/E
11.59
PEG Ratio
0.62
P/B Ratio
2.44
EPS
$5.75
Dividend Yield
—
52W Range
$123.02 – $200.44
Beta
1.64
Volume
0.1M
ROE
10.2%
Profit Margin
10.0%
Revenue Growth
4.3%
Gross Margin
70.7%
EV/EBITDA
10.20
Analyst Target
$206.36
The trailing price-to-earnings ratio stands at 25.2x. Forward P/E of 11.6x implies earnings expansion expected. Price-to-book is 2.44x. EV/EBITDA sits at 10.20x. Market capitalization is $10.30B. Revenue is growing at 4.3% on a trailing basis. Earnings are compressing at -12.1%. Profit margins are 10.0%. Return on equity is 10.2%. Beta of 1.64 indicates elevated market sensitivity.
Analyst Consensus
Recommendation
Buy
Low Target
$170.00
Mean Target
$206.36
High Target
$235.00
Based on 14 analysts
About ALGN
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
ALGN Deep Dive Analysis
Bottom Line
Verdict
OvervaluedBest for
Higher-risk tolerance investorsWatch out for
Premium valuation, High volatility, Earnings declineNon-zero inputs
4/5Counts non-zero values for price, P/E, beta, macro risk, and revenue growth; zero may mean unavailable or be a genuine zero.
Align Technology, Inc. (ALGN) trades above our multi-model fair value estimate of $112.08 by approximately 22.7%. Trailing P/E: 25.2x. Profitability signals include profit margin of 10.0% and return on equity of 10.2%. Recent growth metrics show revenue growth of 4.3% and earnings growth of -12.1%. Risk profile: elevated market beta of 1.64. Consensus: buy.
Valuation, Growth & Risk
Valuation
Overvalued
P/E 25.2x
Price is above what fundamentals suggest.
Growth
Stable
Rev 4.3%
Revenue is moving sideways.
Risk
Elevated
Beta 1.64
Expect bigger swings than the market.
Valuation Snapshot
Align Technology, Inc. (ALGN) trades above our multi-model fair value estimate of $112.08 by approximately 22.7%. The trailing price-to-earnings ratio stands at 25.2x. Forward P/E of 11.6x suggests earnings compression ahead. Price-to-sales is 2.5x. Price-to-book is 2.4x. EV/EBITDA sits at 10.2x. Market capitalization is $10.30B.
Why it matters: Paying a premium works only if the company keeps growing faster than expected.
Growth & Profitability
Revenue is growing at 4.3% on a trailing basis. Earnings are compressing at -12.1%. Profit margins are 10.0%. Return on equity is 10.2%. Return on assets is 7.6%.
Why it matters: Stable revenue is fine, but watch for margin pressure that could limit profit growth.
Risk Profile
Beta of 1.64 indicates elevated market sensitivity. Net debt position is $-981748976.00.
Why it matters: A riskier stock can fall more in a downturn. Make sure your portfolio can handle the volatility.
Analyst Context
Analyst consensus target of $206.36 implies 42.4% upside. Target range spans $170.00 to $235.00. 14 analysts cover the stock. Consensus recommendation: buy.
Why it matters: Analyst targets reflect what professionals expect over 12 months. A wide gap between price and target can mean the market disagrees with the consensus.
Data Methodology & Sources
Market Data (Facts)
- Price, volume, and market cap: Yahoo Finance (may be delayed)
- P/E, EPS, revenue, and debt: Yahoo Finance fundamentals
- Analyst estimates: Yahoo Finance (coverage and update times vary)
- Insider transactions: Yahoo Finance (reporting may be delayed)
QuantSoar Model (Derived)
- Fair value: available outputs from seven models; outliers are filtered using MAD (k=3.5), then combined with fixed model weights.
- Margin of Safety = (Fair Value − Displayed Price) / Displayed Price × 100
- Composite Score: 40% Value + 30% Momentum + 30% Risk
- Verdict Gauge: Base 50 + Valuation (up to ±25) + Whale sentiment (up to ±10) + Insider buying (+5) + Macro risk (up to ±10) + Technical signal (up to ±10). Analyst consensus is separate.
Model outputs are estimates based on available data and are not investment advice. Cross-check with primary sources before making investment decisions.
ALGN Overvalued
Align Technology, Inc. (ALGN) trades above our multi-model fair value estimate of $112.08 by approximately 22.7%.
Frequently Asked Questions
ValuationIs ALGN stock overvalued right now?
ValuationWhat is ALGN fair value based on current fundamentals?
RiskHow risky is ALGN compared with other stocks?
GrowthIs ALGN still growing?
AnalystWhat do analysts think about ALGN?
CatalystWhat could change the investment case for ALGN?
Related Stocks
About the Author
Phasakorn Traklang (Peach) — Founder
Phasakorn Traklang (Peach) is the founder of QuantSoar, bringing expertise in SEO, web development, and technical analytics to build an AI-powered investment platform accessible to retail investors worldwide.
Connect on LinkedInInvestment Disclaimer: Tax treatment can depend on tax residence, account type, and tax year. This information is general and is not personal tax or investment advice. SEC
Data: Yahoo Finance / SEC EDGAR / Alpha Vantage / Finnhub. AI outputs verified against source data.